The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of genomic grade index to improve tumor grading of invasive lobular breast carcinoma.
D. Fumagalli
No relevant relationships to disclose
O. Metzger
No relevant relationships to disclose
I. Veys
No relevant relationships to disclose
A. Catteau
Employment or Leadership Position - Ipsogen
S. Michiels
No relevant relationships to disclose
H. Sandy
No relevant relationships to disclose
R. Salgado
No relevant relationships to disclose
S. K. Singhal
No relevant relationships to disclose
K. V. Saini
No relevant relationships to disclose
C. Galant
No relevant relationships to disclose
N. Galland
No relevant relationships to disclose
F. Bertucci
No relevant relationships to disclose
H. P. Peyro Saint Paul
Employment or Leadership Position - Ipsogen
Stock Ownership - Ipsogen
M. J. Piccart-Gebhart
No relevant relationships to disclose
C. Sotiriou
No relevant relationships to disclose
D. Larsimont
No relevant relationships to disclose